HomeNewsBusinessEconomyCOVID-19 impact | 21 million jobs added in May, no increase in salaried jobs: CMIE

COVID-19 impact | 21 million jobs added in May, no increase in salaried jobs: CMIE

The report noted that there was no increase in salaried jobs in May, with the number having seen a marginal decline instead (from 68.4 million in April to 68.3 million in May).

June 02, 2020 / 20:21 IST
Story continues below Advertisement
Representative Image
Representative Image

The month of May saw 21 million added jobs, according to a report by the Centre for Monitoring Indian Economy (CMIE). This, even as the unemployment rate for the month stood at 23.5 percent, the same as that for April.

"Of the 21 million jobs that got added in May, 14.4 million were of small traders and wage labourers. This workforce was the most vulnerable to the lockdown. They account for about a third of the total employed population," the report said.

Story continues below Advertisement

It added, "In April, 71 percent of them had lost jobs. As the economy has been opening up gradually in parts of the country, these are back to their business. Since these are predominantly self-employed persons it is relatively easy for them to resume work when conditions permit."

The labour participation rate improved from 35.6 percent to 38.2 percent in May.Labour market conditions improved during the month with a rise in the labour force participation rate (LFPR), the report said. LFPR is a measure of the country's labour force, i.e. the section of working population in the age group of 16-64 in the economy currently employed or seeking employment.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show